1–10 of 111 results for AMD-Non-Neovascular
Elamipretide Protection Against Photoreceptor Loss in Dry AMD: Predictive Baseline Quantitative Ellipsoid Zone Integrity Parameters in ReCLAIM-2
David R Lally, MD
Annual Meeting Talks
2025
Retro-Mode (RM): A Newer Insight Into Dry Age-Related Macular Degeneration
SHILPI H NARNAWARE, ICO ( Retina) , FAICO ( Vitreo-Retina)
Vessel Density Changes in Choroid, Choriocapillaris, Deep and Superficial Retinal Plexues on OCTA in Various Stages of ARMD
Prashant Keshao Bawankule, M.S.
Delayed Near-Infrared Analysis (DNIRA) Identifies Novel and Changing Features of Nonexudative (Dry) Age-Related Macular Degeneration (AMD): A Longitudinal Study
Shelley Boyd, MD, FRCS(C)
A 'Digital Twin' Approach to Modeling Geographic Atrophy Growth
Naresh Mandava, MD
Biomarker-Based Efficacy Analysis of Intravitreal CFH Supplementation in a Phase 2 Trial
David M. Brown, MD
Safety, Tolerability, and Properties of Novel C3 Inhibitor BI-C in Patients With Geographic Atrophy
Brian B. Berger, MD
Deactivation of CD163+ Retinal Macrophages With AVD-104 Siglec Agonism Can Restore Photoreceptor Function and Vision in Geographic Atrophy
Eleonora Lad, MD, PhD
Changes in Hyperautofluorescence Area and RPE/Outer Retinal Layer Thickness in the Phase 2a SIGLEC Study Assessing AVD-104 for the Treatment of GA
Carl D. Regillo, MD
Safety and Efficacy of OCU410, a Novel Modifier Gene Therapy, for Treatment of Geographic Atrophy: Phase 1/2 Study Update